Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

By E. Björnsson, Ó. Bergmann, H. Björnsson, R. B. Kvaran, S. Olafsson. Gastroenterology, 2013

826 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study (2015, neutral): “12 White 85 77 Black or African-American 7 13 Other/Multiracial 8 10 BMI (kg/m2, mean [SD]) 27 [5] 28 [6.”
RUCAM in Drug and Herb Induced Liver Injury: The Update (2015, background): “DILI Various synthetic drugs Iceland Europe 2013 Björnsson [153]”
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases (2019, background): “(187,189,191) Minocycline,(187,192-198) nitrofurantoin,(187,199-205) and infliximab(206-221) have been most commonly incriminated; and multiple other agents have been implicated (Table 5).”
EASL Clinical Practice Guidelines: Drug-induced liver injury. (2019, background): “this study, amoxicillin-clavulanate, was later confirmed to be the most common agent in other prospective studies.(15,16,48) Since the original report from the Spanish DILI registry, several”
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. (2021, background): “In a population-based study, 23% of patients with DILI were hospitalized and the most common symptom was jaundice (16).”